[NEW] Webinar Spotlight
CiPA initiative and validation of high-throughput methods to characterize compound effects in human iPSC-derived cardiomyocytes
Join us for this webinar with Eurofins as we discuss the assessment of potential cardiotoxicity of compounds with Comprehensive in vitro Proarrhythmia Assay (CiPA), the new cardiac safety testing paradigm that includes in vitro assays using human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CM).
To adopt this paradigm, we developed a high-throughput hiPSC-CM assay using calcium-sensitive dyes that exhibit fast kinetic fluorescence detected by the high-speed fluorescence imaging platform, the FLIPR® Penta system.
- 2020년 1월 15일 새벽 1시
- 8 AM PST / 4 PM GMT / 5 PM CET January, 14th, 2020